SET-Binding Factor 2

Alternative Names

  • SBF2
  • Myotubularin-Related 13
  • MTMR13
  • KIAA1766
Back to search Result
OMIM Number

607697

Gene Map Locus
11p15

Description

SBF2 gene is also known as the myotubularin- related 13 (MTMR13) gene. This gene encodes the SBF2, or MTMR13, protein which is thought to play a role in cellular communication or the signaling network that is essential for the production of myelin in the neurons. It is also suggested that SBF2 protein has a role in the development of trabecular meshwork that surround the iris in the eyes. MTMR13 is a newly discovered protein that shares extensive homology with proteins from the myotubularin family, especially with MTMR5 which has 60% identity for the full length sequence. Mutations in the SBF2 gene alter the structure of the produced protein and result in a loss of the protein's function. Thus, myelin will have irregular structure (out-folded) which is a specific sign of Charcot-Marie-Tooth disease type 4B2. Glaucoma occurs, if mutations in SBF2 gene cause complete loss of protein function. On the other hand, partial loss of protein function will not cause glaucoma.

Molecular Genetics

Normal SBF2 gene has at least 40 exons spanning about 600 kb. The product of this gene is the SPF2 protein which is a 1849-amino acid member of the pseudophosphatase branch of myotubularins. Mutations in the SBF2 gene cause Charcot-Marie-Tooth disease, type 4B2 (CMT4B2). A homozygous in-frame deletion of SBF2 exons 11 and 12 has been detected in one family with CMT4B2. Two nonsense mutations have also been described in CMT4B2 patients and they were in exons 23 and 27. It is thought that these mutations disrupt an N-terminal domain of SBF2 protein which is highly protected and may be important in sequestering proteins in the cytoplastic compartment.

Epidemiology in the Arab World

View Map

Other Reports

Morocco

Azzedine et al. (2003) detected a homozygous nonsense mutation in the MTMR13 gene of a female with Charcot-Marie-Tooth neuropathy type 4B2 (CMT4B2) with early-onset glaucoma. Two other sibs, one females and one male, were also affected with CMT4B2 and early-onset glaucoma. The three affected sibs were the product of a consanguineous marriage. The affected sibs, their parents, and one other normal brother were genotyped with microsatellite markers. Also, linkage analysis, sequencing of the MTMR13 gene, RT-PCR, and polygenic analysis and protein domain prediction were performed. A nonsense mutation [2875C->T (Gln956Stop)] in exon 23 was identified in an affected female that was not presented in the normal control. That mutation was predicted to result in a truncated protein with deletion of the PTPc/DSPc and SID homology domains. Truncation of approximately half of the protein might also result in instability. MTMR13 was thought to be the first pseudophosphatase mutated in human disorders. Because there was apparently no complementation of MTMR13 loss of function by pseudophosphatase homologues in the target tissues, Azzedine et al. (2003) suggested that MTMR13 had a specific function in the peripheral nervous system and eye or that the level or pattern of expression of myotubularins differed.

Tunisia

Azzedine et al. (2003) identified a homozygous nonsense mutation in the MTMR13 gene of a female with Charcot-Marie-Tooth neuropathy type 4B2 (CMT4B2) and early-onset glaucoma. By studying the pedigree, three other females were also affected with CMT4B2 and early-onset glaucoma. The four affected females were the product of consanguineous marriages. The patients and other 15 normal family members were genotyped with microsatellite markers. Also, linkage analysis, sequencing of the MTMR13 gene, RT-PCR, and polygenic analysis and protein domain prediction were performed. A nonsense mutation [3586C->T (Arg1196 Stop)] in exon 27 was identified in an affected female that was not presented in the normal control. That mutation was predicted to result in a truncated protein with deletion of the PTPc/DSPc and SID homology domains. Truncation of approximately half of the protein might also result in instability.

© CAGS 2024. All rights reserved.